RTOG 0436, A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who are Treated Without Surgery

December 23, 2009
5926-CTO
Cancer - Gastro/ Esophageal

Patients must be between 18 and 75 years of age; Must not have had prior chemotherapy for your esophageal cancer; Participant should not have had prior radiation therapy that would result in overlap of planned radiation therapy fields.

Open
Tiffany Pearce